The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

TAK-659 in combination with NKTR-214 and anti-PD-1 therapy leads to complete and sustained tumor regression and immune memory in pre-clinical syngeneic models.

Jie  Yu

Employment - Takeda

Jessica Huck  Sappal

Employment - Blueprint Medicines (I); Takeda

Stock and Other Ownership Interests  - Blueprint Medicines (I)

Patents, Royalties, Other Intellectual Property - Takeda (Inst)

Mengkun  Zhang

Employment - Takeda; Takeda (I)

Karuppiah  Kannan

Employment - Takeda; Takeda (I)

Jonathan  Zalevsky

Employment - Nektar

Stock and Other Ownership Interests  - Nektar